We are live on ! Find out more
NURO

NeuroMetrix, Inc. Common Stock

Delisted

NURO was delisted on the 1st of May, 2025.

7 hedge funds and large institutions have $371K invested in NeuroMetrix, Inc. Common Stock in 2017 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 1

22% less funds holding

Funds holding: 97 (-2)

26% less capital invested

Capital invested by funds: $500K → $371K (-$129K)

50% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 4

Holders
7
Holders Change
-2
Holders Change %
-22.22%
% of All Funds
0.17%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
4
Reduced
1
Closed
4
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Renaissance Technologies
1
Renaissance Technologies
New York
$99K +$83.8K +270 +141%
Bank of New York Mellon
2
Bank of New York Mellon
New York
$76K +$101K +324 +1,045%
VKH
3
Virtu KCG Holdings
New York
$71K +$34.1K +110 +50%
Goldman Sachs
4
Goldman Sachs
New York
$43K +$62.4K +201 New
BlackRock
5
BlackRock
New York
$41K -$3.72K -12 -6%
Morgan Stanley
6
Morgan Stanley
New York
$31K +$45.3K +146 New
Manulife (Manufacturers Life Insurance)
7
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$10K +$1.24K +4 +10%
SM
8
Sabby Management
Florida
-$187K -472 Closed
Vanguard Group
9
Vanguard Group
Pennsylvania
-$20K -50 Closed
PAG
10
Private Advisor Group
New Jersey
-$12K -31 Closed
Northern Trust
11
Northern Trust
Illinois
-$8K -20 Closed

NURO Hedge Fund Activity: Q2 2017 in Review

7 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in NeuroMetrix, Inc. Common Stock (NURO) for Q2 2017, worth a combined $371K — down 26% from $500K a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of NURO and 2 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 4 added.

The largest buyer was Bank of New York Mellon, adding an estimated $101K. The largest seller was Sabby Management, exiting entirely with an estimated $187K sold.

  • 7 institutional investors held NeuroMetrix, Inc. Common Stock (NURO) as of Q2 2017, down from 9 in Q1 2017.
  • Funds reported $371K of NeuroMetrix, Inc. Common Stock stock for Q2 2017, down 26% quarter-over-quarter.
  • 2 funds opened new NeuroMetrix, Inc. Common Stock positions in Q2 2017 and 4 closed out, a net change of -2 holders.
  • The largest NeuroMetrix, Inc. Common Stock buyer in Q2 2017 was Bank of New York Mellon, an estimated $101K added.
  • The largest NeuroMetrix, Inc. Common Stock seller in Q2 2017 was Sabby Management, an estimated $187K sold.

Based on aggregated 13F filings for Q2 2017.